Fresh Tracks Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Fresh Tracks Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2018 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
  • Fresh Tracks Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2023 was $5K, a 44.4% decline year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Interest Expense for 2023 was $5K, a 44.4% decline from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Interest Expense for 2022 was $9K, a 87% decline from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Interest Expense for 2021 was $69K.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $5K $0 -$3K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $8K $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8K $2K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $8K $3K -$1K -25% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $9K $3K -$1K -25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $10K $0 -$1K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11K $2K -$28K -93.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $39K $4K -$30K -88.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $69K $4K +$4K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $65K $1K +$1K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $64K $30K +$30K Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-09-01
Q1 2021 $34K $34K +$34K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $0 -$1.1M -100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $0 -$660K -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $0 -$224K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $1.1M +$831K +311% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $660K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $224K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 $267K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.